Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patientsCatherine Patte, Mitchell S. Cairo, Anne Aupérin et al.|Blood|2006Cited by 431
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescentsMitchell S. Cairo, Catherine Patte, Anne Aupérin et al.|Blood|2006Cited by 362
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadVéronique Minard‐Colin, Catherine Patte, Laurence Brugières et al.|Journal of Clinical Oncology|2015Cited by 288
Revised International Pediatric Non-Hodgkin Lymphoma Staging SystemAngelo Rosolen, Mitchell S. Cairo, Sherrie L. Perkins et al.|Journal of Clinical Oncology|2015Cited by 238
Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B‐cell non‐Hodgkin’s lymphoma: results of the FAB/LMB 96 international study*Mary Gerrard, Catherine Patte, Mitchell S. Cairo et al.|British Journal of Haematology|2008Cited by 201